Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer,Journal of Clinical Oncology

当前位置： X-MOL 学术 › J. Clin. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAFV600-Mutant Metastatic Non–Small-Cell Lung Cancer
Journal of Clinical Oncology ( IF 45.3 ) Pub Date : 2023 , DOI: 10.1200/jco.23.00774
Gregory J Riely ₁ , Egbert F Smit ₂ , Myung-Ju Ahn ₃ , Enriqueta Felip ₄ , Suresh S Ramalingam ₅ , Anne Tsao ₆ , Melissa Johnson ₇ , Francesco Gelsomino ₈ , Raymond Esper ₉ , Ernest Nadal ₁₀ , Michael Offin ₁ , Mariano Provencio ₁₁ , Jeffrey Clarke ₁₂ , Maen Hussain ₉ , Gregory A Otterson ₁₃ , Ibiayi Dagogo-Jack ₁₄ , Jonathan W Goldman ₁₅ , Daniel Morgensztern ₁₆ , Ann Alcasid ₁₇ , Tiziana Usari ₁₈ , Paul Wissel ₁₉ , Keith Wilner ₂₀ , Nuzhat Pathan ₂₀ , Svitlana Tonkovyd ₂₁ , Bruce E Johnson ₂₂

Affiliation

Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, the Netherlands.
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Winship Cancer Institute of Emory University, Atlanta, GA.
MD Anderson Cancer Center, Houston, TX.
Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN.
Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Florida Cancer Specialists, Fort Myers, FL.
Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain.
Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Duke Cancer Center, Durham, NC.
Ohio State University Comprehensive Cancer Center, Columbus, OH.
Massachusetts General Hospital, Boston, MA.
David Geffen School of Medicine at UCLA, Los Angeles, CA.
Washington University School of Medicine, St Louis, MO.
Pfizer, Collegeville, PA.
Pfizer, Milan, Italy.
Pfizer, New York, NY.
Pfizer, La Jolla, CA.
Pfizer, Warsaw, Poland.
Dana-Farber Cancer Institute, Boston, MA.